⌘K

Home/Filings/4/0001493152-21-018908

4//SEC Filing

Karah Hila 4

Accession 0001493152-21-018908

CIK 0001857044other

View on SEC.gov Company Profile

Filed

Aug 5, 8:00 PM ET

Accepted

Aug 6, 5:00 PM ET

Size

5.3 KB

Accession

0001493152-21-018908

Insider Transaction Report

Form 4

Period: 2021-08-04

Indaptus Therapeutics, Inc.INDP

Director

Transactions

Award
Stock Option (right to buy)
2021-08-04+13,750→ 13,750 total
Exercise: $8.87Exp: 2031-08-04→ Common Stock (13,750 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable on August 4, 2022.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1

filerCIK 0001668116

Filing Metadata

Form type: 4
Filed: Aug 5, 8:00 PM ET
Accepted: Aug 6, 5:00 PM ET
Size: 5.3 KB

View on SEC.gov